| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $6.4M | +10.6% | +29.2% |
| SG&A Expense | $2.6M | +18.8% | +36.6% |
| Operating Income | -$9.0M | -12.8% | -31.2% |
| Pre-tax Income | -$8.6M | -12.0% | -37.5% |
| Income Tax | $6K | +0.0% | -14.3% |
| Net Income | -$8.6M | -12.0% | -37.4% |
| EPS (Basic) | -$0.17 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.3M | -19.1% | -19.5% |
| Short-term Investments | $52.0M | +100.5% | +12.9% |
| Accounts Receivable | $260K | +61.5% | -10.3% |
| Current Assets | $56.2M | +80.9% | +10.7% |
| Total Assets | $57.0M | +81.3% | +8.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.3M | — | — |
| Capital Expenditures | $34K | — | — |
| Investing Cash Flow | -$10.2M | — | — |
| Financing Cash Flow | $31.8M | — | — |
| Free Cash Flow | -$21.3M | — | — |
| +5.6% |
| -13.3% |
| $5.3M |
| +28.0% |
| +22.6% |
| Stockholders' Equity | $51.6M | +90.0% | +7.6% |